NeoGenomics Newsroom

NeoGenomics Is Maintained at Neutral by B of A Securities

Dow JonesDec 14 00:08 · Ratings

BofA Securities Maintains NeoGenomics(NEO.US) With Hold Rating, Raises Target Price to $19

Futu NewsDec 13 21:31 · Ratings

NeoGenomics Study Highlights CtDNA's Potential To Predict Recurrence In High-Risk Melanoma; RaDaR Sequencing Assay Identifies Molecular Residual Disease Across Broader Patient Range, Enabling Earlier Detection And Prognosis Monitoring

BenzingaDec 11 21:08

NeoGenomics' Newly Published Study Underscores Potential of CtDNA as a Predictive Tool for Monitoring Patients With High-Risk Melanoma

BusinesswireDec 11 21:05

Strong Week for NeoGenomics (NASDAQ:NEO) Shareholders Doesn't Alleviate Pain of Three-year Loss

Simply Wall StDec 11 19:57

NeoGenomics Analyst Ratings

BenzingaDec 10 23:59 · Ratings

Jefferies Initiates NeoGenomics(NEO.US) With Buy Rating, Announces Target Price $22

Futu NewsDec 10 05:31 · Ratings

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

BusinesswireDec 9 21:10

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research

BusinesswireDec 5 20:00

Neo Medical's Spine Care Platform Fully Approved Under EU Medical Device Regulation Directive

BusinesswireDec 2 15:00

NeoGenomics To Present Four Studies At AMP 2024 Showcasing CtDNA And NGS Advancements For Cancer Diagnostics And Personalized Treatment

BenzingaNov 19 21:19

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of CtDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

BusinesswireNov 19 21:15

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking AlphaNov 16 04:55

Felicia Williams Joins NeoGenomics Board of Directors

BusinesswireNov 14 21:10

Express News | Felicia Williams Joins Neogenomics Board of Directors

BreakingsNov 14 21:10

Earnings Scheduled For November 14, 2024

BenzingaNov 14 16:32

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

BusinesswireNov 8 20:00

A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $18 to $21

Futu NewsNov 7 21:00 · Ratings

A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $18 to $20

Futu NewsNov 6 21:00 · Ratings

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), NeoGenomics (NEO) and Ultragenyx Pharmaceutical (RARE)

TipRanksNov 6 20:02 · Ratings